TARGET CELL DAMAGE BY IMMUNE MECHANISMS
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
批准号:
2463757
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
为了确定CTL细胞毒性的分子途径,我们测试了
ICE家族蛋白水解酶(Caspase)前体可能是
生理上相关的目标颗粒酶底物。其他实验室也有
生化显示,颗粒酶B激活半胱氨酸酶,从而导致
核破坏。因此,我们测试了两种类型的caspase抑制剂
它们阻断颗粒胞吐途径和Fas的能力
CTL细胞毒作用途径。我们发现,虽然通过Fas的细胞死亡
Ligand/Fas通路与颗粒剂诱导的凋亡核损伤
胞吐途径需要caspase,通过颗粒靶向裂解
胞吐作用途径不能。使用的第一类caspase抑制剂
是多肽氟甲基酮--zVAD-FMK(ICE抑制剂),
BD-FMK(CPP32但不是ICE抑制剂)和ZfA-FMK(对照
组织蛋白酶B抑制剂)。这些都不能抑制对asp的选择性。
丝氨酸蛋白酶颗粒酶B:zVAD-FMK和BD-FMK均完全
靶细胞裂解受阻(~(51)Cr释放)与核凋亡
ZfA-FMK诱导Fas配体诱导CTL杂交瘤的形态
没有,证实了caspase在这条死亡途径中的作用。什么时候
用非Fas载体检测颗粒的胞吐途径
靶细胞和常规克隆的CTL,这些含有天冬氨酸转运蛋白的FMK
抑制剂完全阻断了凋亡的核形态,但没有
对靶向裂解有显著影响。这些结果已经得到证实
用第二种类型的半胱氨酸天冬氨酸氨基转移酶抑制剂,杆状病毒蛋白p35,
阻止该家族的所有已知成员,但不阻止Granzyme B in
这些实验我们在靶细胞中瞬时表达了p35。
转染法测定CTL的释放能力
共转染半乳糖苷酶。尽管p35有效地阻止了裂解
通过Fas途径,通过颗粒胞吐途径的裂解不是
明显受到抑制。因此我们得出结论,虽然半胱氨酸酶是
诱导两种CTL效应器凋亡核损伤的途径
途径,颗粒胞吐途径使用另一个更快的细胞
不依赖半胱氨酸天冬氨酸酶的死亡途径。
英文摘要
To define the molecular pathway of CTL cytotoxicity, we have tested the
possibility that precursors of ICE-family proteases (caspases) are the
physiologically relevant target granzyme substrates. Other labs have
shown biochemically that granzyme B activates caspases which cause
nuclear damage. We thus tested two types of caspase inhibitor for
their ability to block both the granule exocytosis pathway and the Fas
pathway of CTL cytotoxicity. We find that while cell death via the Fas
ligand/Fas pathway and apoptotic nuclear damage induced by the granule
exocytosis pathway requires caspases, target lysis via the granule
exocytosis pathway does not. The first class of caspase inhibitor used
was peptide fluoromethyl ketones-- ZVAD- FMK (an ICE inhibitor),
BD-FMK (a CPP32 but not ICE inhibitor), and ZFA-FMK (a control
cathepsin B inhibitor). None of these inhibits the asp-selective
serine protease granzyme B. Both ZVAD-FMK and BD-FMK completely
blocked target cell lysis (51Cr release) and apoptotic nuclear
morphology induced by a Fas ligand bearing CTL hybridoma while ZFA-FMK
did not, confirming a role for caspases in this death pathway. When
the granule exocytosis pathway was examined using non-Fas bearing
targets and conventional cloned CTL, these asp-containing FMK
inhibitors completely blocked apoptotic nuclear morphology but had no
significant effect on target lysis.These results have been confirmed
with second type of caspase inhibitor, the Baculovirus protein p35,
which blocks all known members of this family but not granzyme B. In
these experiments we expressed p35 in target cells by transient
transfection and measured the ability of CTL to release
cotransfected-galactosidase. Although p35 effectively blocked lysis
via the Fas pathway, lysis via the granule exocytosis pathway was not
significantly inhibited. Thus we conclude that while caspases are part
of the pathway inducing apoptotic nuclear damage for both CTL effector
pathways, the granule exocytosis pathway uses another, more rapid, cell
death pathway which is independent of caspases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金